Vienna-based HealthTech scaleup XUND, which specialises in constructing Software program as a Medical Gadget (SaMD), has efficiently closed a €6 million pre-Sequence A funding spherical to develop throughout Europe, with a strategic concentrate on DACH and the UK.
The funding spherical was led by Lead Ventures and joined by J&T Ventures, with continued assist from present buyers MassMutual Ventures, tba community, and LANA Ventures, who reaffirmed their dedication to XUND’s mission and progress trajectory.
Tamás Petrovics, Co-founder and CEO of XUND: “The most recent funding is a sworn statement to the exhausting work of our crew over the previous years. It would assist us speed up our enlargement throughout Europe whereas advancing the mixing of our medical gadgets and RAVE, our cutting-edge giant language mannequin (LLM) answer. We’re laying the muse for a data-driven, personalised healthcare system that redefines how care is delivered — at present and tomorrow.”
Based in 2018 by Lukas Seper, Tamás Petrovics, and Zoltán Tarabó, XUND specialises in creating SaMD, enabling digital interactions from prevention to analysis. With the imaginative and prescient of bringing readability to a very powerful selections in healthcare, XUND’s merchandise are already utilized by insurers, hospitals, and pharmaceutical firms as the primary digital level of contact.
Immediately, the corporate employs greater than 40 folks throughout its places in Vienna, Budapest, and London.
With new funding and an growing portfolio of MDR-certified SaMD options, XUND is additional strengthening its place as a homegrown European champion in digital well being expertise.
With demand for AI-powered medical gadgets surging throughout the continent, XUND believes they’re well-positioned for speedy progress. Over the approaching months, the corporate will speed up its enlargement in DACH and the UK, leveraging its MDR-certified expertise to allow digital interactions from prevention to analysis.
“We’re thrilled to companion with XUND, an organization that brings readability to a very powerful selections in healthcare. Their dedication to digitising the affected person journey not solely enhances affected person care but additionally streamlines operations for healthcare suppliers. The long-anticipated synthesis of AI expertise in affected person care is lastly occurring extensively and it’s really thrilling to carry down the partitions between new applied sciences and legacy healthcare programs.
“We’ve immense confidence in XUND’s crew and imaginative and prescient, and are wanting to assist their daring enlargement efforts to remodel healthcare supply,” mentioned Balázs Haszonics, Managing Associate at Lead Ventures.
On the identical time, XUND is consolidating its position as a vital infrastructure supplier in Europe’s evolving healthcare panorama — totally aligned with the EU’s newest InvestAI initiative, which plans to mobilize €200 billion for funding in AI options that strengthen technological sovereignty.
David Polach, Associate at J&T Ventures added: “The way forward for healthcare is not only digital — it’s clever, seamless, and deeply built-in. Our funding in XUND is pushed by the thesis that AI-powered SaMD options would be the basis of a extra environment friendly, accessible, and data-driven healthcare system.
“What units XUND aside will not be solely its world-class expertise and the belief it has earned from a few of the greatest names in healthcare but additionally the energy of its founding crew and their daring imaginative and prescient. Their deep experience, relentless execution, and dedication to remodeling digital well being give us full confidence that XUND is poised to turn out to be a worldwide chief, redefining the way forward for healthcare at scale.”
